Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.7K
Overview
51.7K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Decision Making: P-value Method01:09

Decision Making: P-value Method

7.0K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
7.0K
Decision Making: Traditional Method01:14

Decision Making: Traditional Method

5.4K
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
5.4K
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

305
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
305
Decision Making01:20

Decision Making

990
Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
990

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conserved T cell receptor usage underpins recognition of CD1c presenting a mycobacterial lipid.

bioRxiv : the preprint server for biology·2026
Same author

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same author

Integration of functional immunomonitoring assays with PET/CT scans in TB patients identifies on-treatment biomarkers.

bioRxiv : the preprint server for biology·2026
Same author

Risk of progression to pulmonary tuberculosis among household contacts with chest radiographic abnormalities in South Africa.

medRxiv : the preprint server for health sciences·2026
Same author

Interferon gamma release assay and sputum GeneXpert positivity for tuberculosis burden detection in people deprived of liberty in Brazil: a cross-sectional study.

BMC public health·2026
Same author

Is health human resource strain associated with the prevalence of healthcare-associated infections in England? Analysis of a national point prevalence survey.

The Journal of hospital infection·2026

Related Experiment Video

Updated: Feb 4, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making.

Sophie J Rhodes1, Jeremie Guedj2,3, Helen A Fletcher4

  • 11TB Modelling Group, CMMID, TB Centre, London School of Hygiene and Tropical Medicine, London, UK.

NPJ Vaccines
|September 25, 2018
PubMed
Summary

Mathematical modeling was used to predict the most immunogenic dose for tuberculosis (TB) vaccines. The novel Immunostimulation/Immunodynamic framework suggests 0.8-8 micrograms of H-series TB vaccines may be optimal for humans.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.0K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.0K

Related Experiment Videos

Last Updated: Feb 4, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.0K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.0K

Area of Science:

  • Immunology
  • Mathematical Biology
  • Vaccinology

Background:

  • Mathematical modeling is established for drug dose optimization but not yet for vaccine dose finding.
  • Tuberculosis (TB) vaccine development requires identifying optimal immunogenic doses.
  • Previous studies collected immune response data (IFN-γ secreting CD4+ T cells) in mice and humans for H56 and H1 TB vaccines adjuvanted with IC31.

Purpose of the Study:

  • To apply a novel Immunostimulation/Immunodynamic (IS/ID) mathematical modeling framework to predict the most immunogenic dose for TB vaccines in humans.
  • To translate multi-dose TB vaccine immune responses from preclinical (mice) to clinical (humans) settings.
  • To establish a new methodology for vaccine dose finding.

Main Methods:

  • Utilized a two-compartment mathematical model to describe the dynamics of post-vaccination IFN-γ T cell response.
  • Fitted the model to mouse and human immune response data separately using nonlinear mixed effects methods.
  • Employed vaccine dose allometric scaling to predict the most immunogenic human dose based on preclinical data.

Main Results:

  • The IS/ID model successfully described the dynamics of T cell responses in both mice and humans.
  • Predicted that doses of 0.8-8 micrograms of H56 + IC31 vaccine in humans may be the most immunogenic at a late time point (224 days).
  • Indicated that these lower doses could be as or more immunogenic than higher doses.

Conclusions:

  • The Immunostimulation/Immunodynamic mathematical modeling framework is a novel tool for predicting optimal vaccine doses.
  • This approach has the potential to accelerate TB vaccine development by refining dose-finding strategies.
  • The study demonstrates the utility of mathematical modeling in translating preclinical immune data to predict human vaccine efficacy.